Curative effect of second curettage for treatment of gestational trophoblastic disease - Results of the Belgian registry for gestational trophoblastic disease.

OBJECTIVE: We assessed the curative effect of a second curettage in patients with persistent hCG serum levels after first curettage for a gestational trophoblastic disease (GTD). STUDY DESIGN: This prospective observational study used the data of the Belgian register for GTD between July 2012 and January 2017. We analysed the data of patients who underwent a second curettage. We included 313 patients in the database. Primary endpoints were need for second curettage and chemotherapy. RESULTS: Thirty-seven patients of the study population (12 %) underwent a second curettage. 20 had persistent hu... Mehr ...

Verfasser: Vandewal, Aleide
Delbecque, Katty
Van Rompuy, Anne-Sophie
Noel, Jean-Christophe
Marbaix, Etienne
Delvenne, Philippe
Nisolle, Michelle
Van Nieuwenhuysen, Els
Kridelka, Frédéric
Vergote, Ignace
Goffin, Frédéric
Han, Silenyy N
Dokumenttyp: Artikel
Erscheinungsdatum: 2021
Verlag/Hrsg.: Elsevier Scientific Publishers
Schlagwörter: Belgium / Chorionic Gonadotropin / Curettage / Female / Gestational Trophoblastic Disease / Humans / Hydatidiform Mole / Pregnancy / Registries / Uterine Neoplasms / Gestational trophoblastic neoplasia / Molar pregnancy / Second curettage
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26495771
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/2078.1/261568